United Kingdom Diabetes Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers UK Diabetes Devices Market Size and It is Segmented Into Management Devices (insulin Pumps (technology and Components (insulin Pump Devices, Insulin Pump Reservoirs, and Infusion Sets)), Insulin Syringes, Insulin Pens (cartridges in Reusable Pens, Disposable Insulin Pens), and Jet Injectors), and Monitoring Devices (self-Monitoring Blood Glucose (glucometer Devices, Blood Glucose Test Strips, and Lancets), Continuous Glucose Monitoring (sensors and Durables)) and End User ( Hospital/clinics, and Home/Personal). the Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

United Kingdom Diabetes Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

UK Diabetes Devices Market Size

View Global Report
United Kingdom (UK) Diabetes Care Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 89.98 Million
Market Size (2030) USD 124.55 Million
CAGR (2025 - 2030) 6.72 %

Major Players

United Kingdom (UK) Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of United Kingdom (UK) Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

UK Diabetes Devices Market Analysis

The United Kingdom Diabetes Care Devices Market size is estimated at USD 89.98 million in 2025, and is expected to reach USD 124.55 million by 2030, at a CAGR of 6.72% during the forecast period (2025-2030).

The COVID-19 pandemic had a substantial impact on the United Kingdom's diabetes care devices. According to The British Diabetic Association, 'The pandemic has had, and continues to have, a huge impact on our society. However research and data have shown that people with diabetes have been disproportionately affected by COVID-19, particularly in terms of poorer outcomes when contracting the virus. That's why preventing or delaying cases of type 2 diabetes is more important than ever before.'

The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care, through virtual consultations between healthcare providers and people with diabetes, and the use of diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the diabetes care device market's growth.

The rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care products. According to The British Diabetic Association, Diabetes prevalence 2021 data shows an increase in the number of people living with a diabetes diagnosis in the UK: an increase of more than 150,000 from 2020. It is estimated that more than 13.6 million people are at increased risk of type 2 diabetes in the UK. At this rate, the number of people with diabetes, including the undiagnosed population, is expected to rise to 5.5 million by 2030.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

UK Diabetes Devices Industry Overview

The United Kingdom diabetes care devices market is semi-consolidated, with few significant and generic players. Manufacturers drove constant innovations to compete in the market. The major players, such as Abbott and Medtronic, underwent many mergers, acquisitions, and partnerships to establish market dominance while also adhering to organic growth strategies, which is evident from the R&D spending of these companies. The manufacturers of insulin delivery devices are spending a massive amount on the R&D of the devices.

UK Diabetes Devices Market Leaders

  1. Insulet Corporation

  2. Roche Diabetes Care

  3. Abbott Diabetes Care

  4. Dexcom Inc.

  5. Medtronic PLC

  6. *Disclaimer: Major Players sorted in no particular order
United Kingdom (UK) Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

UK Diabetes Devices Market News

  • May 2023: The National Institute of Clinical Excellence (NICE) made a significant advancement by revising its guidelines to incorporate CGMs and flash glucose monitors, which are automated glucose monitoring devices, for children diagnosed with type 2 diabetes. This development marks a significant milestone for the United Kingdom, as it eliminates the sole reliance on fingerstick testing to monitor blood sugar levels in children. Although fingersticks have been valuable, they can induce stress and discomfort, particularly for children and their families who need to perform numerous tests daily.
  • April 2022: Abbott, CamDiab, and Ypsomed announced they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system. The initial focus of the partnership will be on European countries. The connected, smart wearable solution is designed to continuously monitor a person's glucose levels and automatically adjust and deliver the right amount of insulin at the right time, removing the guesswork of insulin dosing.

UK Diabetes Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Management Devices
    • 5.1.1 Insulin Pump
    • 5.1.1.1 Technology
    • 5.1.1.1.1 Tethered Insulin Pump
    • 5.1.1.1.2 Tubeless Insulin Pump
    • 5.1.1.2 Component
    • 5.1.1.2.1 Insulin Pump Device
    • 5.1.1.2.2 Insulin Pump Reservoir
    • 5.1.1.2.3 Infusion Set
    • 5.1.2 Insulin pens
    • 5.1.2.1 Cartridges in Reusable Pens
    • 5.1.2.2 Insulin Disposable Pens
    • 5.1.3 Insulin Syringes
    • 5.1.4 Jet Injectors
  • 5.2 Monitoring Devices
    • 5.2.1 Self-monitoring Blood Glucose
    • 5.2.1.1 Glucometer Devices
    • 5.2.1.2 Blood Glucose Test Strips
    • 5.2.1.3 Lancets
    • 5.2.2 Continuous Glucose Monitoring
    • 5.2.2.1 Sensors
    • 5.2.2.2 Durables (Receivers and Transmitters)
  • 5.3 End User
    • 5.3.1 Hospital/Clinics
    • 5.3.2 Home/Personal

6. MARKET INDICATORS

  • 6.1 Type 1 Diabetes Population
  • 6.2 Type 2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Diabetes Care
    • 7.1.3 LifeScan (Johnson & Johnson)
    • 7.1.4 Sanofi
    • 7.1.5 Medtronic
    • 7.1.6 Novo Nordisk A/S
    • 7.1.7 Terumo
    • 7.1.8 Eli Lilly
    • 7.1.9 Arkray
    • 7.1.10 Becton Dickinson
    • 7.1.11 Dexcom
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 LifeScan
    • 7.2.1.3 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom
    • 7.2.2.2 Abbott Diabetes Care
    • 7.2.2.3 Others
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Medtronic
    • 7.2.3.2 Novo Nordisk A/S
    • 7.2.3.3 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

UK Diabetes Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The United Kingdom diabetes care devices market is segmented into management devices (insulin pumps (technology and components (insulin pump devices, insulin pump reservoirs, and infusion sets)), insulin syringes, insulin pens (cartridges in reusable pens, disposable insulin pens), and jet injectors), and monitoring devices (self-monitoring blood glucose (glucometer devices, blood glucose test strips, and lancets) and continuous glucose monitoring (sensors and durables)) and End User ( Hospital/clinics, and Home/Personal). The report offers the value (in USD) and volume (in units) for the above segments.

Management Devices Insulin Pump Technology Tethered Insulin Pump
Tubeless Insulin Pump
Component Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin pens Cartridges in Reusable Pens
Insulin Disposable Pens
Insulin Syringes
Jet Injectors
Monitoring Devices Self-monitoring Blood Glucose Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables (Receivers and Transmitters)
End User Hospital/Clinics
Home/Personal
Need A Different Region or Segment?
Customize Now

UK Diabetes Devices Market Research FAQs

How big is the United Kingdom Diabetes Care Devices Market?

The United Kingdom Diabetes Care Devices Market size is expected to reach USD 89.98 million in 2025 and grow at a CAGR of 6.72% to reach USD 124.55 million by 2030.

What is the current United Kingdom Diabetes Care Devices Market size?

In 2025, the United Kingdom Diabetes Care Devices Market size is expected to reach USD 89.98 million.

Who are the key players in United Kingdom Diabetes Care Devices Market?

Insulet Corporation, Roche Diabetes Care, Abbott Diabetes Care, Dexcom Inc. and Medtronic PLC are the major companies operating in the United Kingdom Diabetes Care Devices Market.

What years does this United Kingdom Diabetes Care Devices Market cover, and what was the market size in 2024?

In 2024, the United Kingdom Diabetes Care Devices Market size was estimated at USD 83.93 million. The report covers the United Kingdom Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United Kingdom Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

UK Diabetes Devices Industry Report

Statistics for the 2025 United Kingdom (UK) Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United Kingdom (UK) Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.